<mods:mods xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" version="3.3" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mods:titleInfo><mods:title>SPECIFIC PATHOMORPHOLOGICAL AND IMMUNOPHENOTYPICAL CHARACTERISTICS OF LYMPHOBLASTIC LEUKEMIA IN CHILDREN</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Zulfiya</mods:namePart><mods:namePart type="family">Salayeva</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Bunyodbek</mods:namePart><mods:namePart type="family">Egamov</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Ushbu maqola bolalarda limfoblastli leykozlarning (LLL) o‘ziga xos patomorfologik va immunofenotipik xususiyatlarini o‘rganishga bag‘ishlangan. Tadqiqotda 2018-2023-yillar davomida Respublika onkogematologiya markazida LLL tashxisi qo‘yilgan 100 nafar bolalarning klinik, laborator, patomorfologik va immunofenotipik ko‘rsatkichlari tahlil qilindi. Natijalar LLL ning asosiy to‘rt immunologik podtipini ajratib ko‘rsatdi: T-hujayrali, V-hujayrali, T/V gibrid hujayrali va aralash miyeloid-limfoid turlari. Ushbu xususiyatlar bolalarda kasallikning kechishini, davolash strategiyasini va uning samaradorligini belgilashda muhim rol o‘ynaydi.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2024-08-30</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Research Science and Innovation house</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>